PharmaCielo Ltd. PCLOF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.70M | -2.60M | -3.31M | -- | -- |
| Total Depreciation and Amortization | 1.08M | 1.21M | 886.10K | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -549.70K | -668.70K | 2.11M | -- | -- |
| Change in Net Operating Assets | -2.89M | -1.32M | -575.80K | -- | -- |
| Cash from Operations | -5.06M | -3.37M | -885.70K | -- | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | 7.31M | 7.29M | 4.84M | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 22.90K | -- | -- |
| Cash from Investing | 7.31M | 7.29M | 4.86M | -- | -- |
| Total Debt Issued | 530.00K | 415.00K | 705.00K | -- | -- |
| Total Debt Repaid | -3.57M | -5.85M | -5.94M | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -2.21M | -3.94M | -3.81M | -- | -- |
| Foreign Exchange rate Adjustments | 11.80K | 1.70K | 17.40K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 50.10K | -27.60K | 186.40K | -- | -- |